Highlights Poolbeg Pharma PLC

Equities

POLB

GB00BKPG7Z60

Biotechnology & Medical Research

Delayed London S.E. Other stock markets 09:05:00 14/07/2025 pm IST			5-day change	1st Jan Change
3.200 ^GBX	0.00%		-1.54%	-54.93%

29/05	Poolbeg Pharma PLC - Shareholder/Analyst Call
27/05	Poolbeg Pharma shares up after US FDA orphan drug designation	AN

Highlights

Poolbeg Pharma's POLB 001 Wins Orphan Drug Designation in US	27/05	MT
Poolbeg upsizes offer; Glenveagh backs outlook	23/05	AN
Poolbeg upsizes fundraise amid strong investor demand	21/05	AN
Poolbeg Pharma PLC Reports Earnings Results for the Full Year Ended December 31, 2024	20/05	CI
Poolbeg Pharma loss widens; launches GBP4 million equity raise	20/05	AN
Earnings Flash (POLB.L) Poolbeg Pharma Reports FY24 Loss GBX-1.16	20/05	MT
Costain wins deal; Focusrite expects revenue hike	20/03	AN
Poolbeg Pharma plc Receives Korean Intellectual Property Office Grant in Korea	20/03	CI
AIM WINNERS & LOSERS: Proteome wins deal; Biome plots AIM exit	21/02	AN
Poolbeg Pharma Says Hookipa Ended Takeover Talks	21/02	MT
FTSE 100 flat as UK data keeps pound above USD1.26	21/02	AN
Poolbeg Pharma shares plummet as Hookipa walks away from possible bid	21/02	AN
Poolbeg Pharma Says Hookipa Terminated Discussions On Proposed Merger	21/02	RE
Hookipa Pharma rules out making offer for Poolbeg Pharma	21/02	AN
Poolbeg Pharma PLC cancelled the acquisition of HOOKIPA Pharma Inc. in a reverse merger transaction.	20/02	CI
Poolbeg Pharma Extends Deadline for Hookipa Pharma Takeover Talks	30/01	MT
Poolbeg Pharma notes Gilead interest in Hookipa fundraise	10/01	AN
Poolbeg and Hookipa deal gets support from major stakeholder	07/01	AN
Hookipa Shareholder Gilead Sciences to Back Poolbeg Merger	07/01	MT
Pound sinks but FTSE 100 starts 2025 with a bang	02/01	AN
Gold, oil supports FTSE 100; pound takes a fall	02/01	AN
Poolbeg Pharma in Talks with Hookipa for Potential Combination	02/01	MT
Poolbeg in early stage talks to combine with US biotech, Hookipa	02/01	AN
Chrysalis settles claims with Revolution Beauty	02/01	AN
Poolbeg Pharma PLC entered into non-binding discussions to acquire HOOKIPA Pharma Inc. for $30.2 million in a reverse merger transaction.	02/01	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Poolbeg Pharma PLC

Equities

POLB

GB00BKPG7Z60

Biotechnology & Medical Research

Highlights

Filters